China Speeds Review Procedures for Approval of Orphan Drugs
Eager to hasten the availability of medicines for rare diseases and life-threatening illnesses to Chinese consumers, China is easing approval procedures for orphan drug imports. At a meeting this summer, the China State Council set a review timeline of just three months... Read More